Key terms

About PHGE

BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest PHGE news

Apr 22 6:16am ET BiomX’s BX211 Phage Therapy: A Revolutionary Approach to Diabetic Foot Osteomyelitis Treatment by TipRanks Apr 18 8:06am ET BiomX appoints Blum to board of directors by TipRanks Apr 15 5:32pm ET BiomX Board Governance Structure and Bylaws Updated by TipRanks Apr 05 2:00am ET Biomx Inc. at a Crossroads: Shareholder Approval Required for Convertible Securities Amid Liquidity Concerns by TipRanks Apr 04 7:53am ET BiomX announces compliance with NYSE guidelines on audit opinion disclosure by TipRanks Apr 03 2:50pm ET Analysts Are Bullish on These Healthcare Stocks: BiomX (PHGE), Daré Bioscience (DARE) by TipRanks Apr 03 10:35am ET BiomX’s Robust Financial Health and Promising Clinical Advancements Bolster Buy Rating by TipRanks Mar 18 7:42am ET BiomX Expands and Strengthens with Strategic Acquisition and Finance Moves by TipRanks Mar 07 6:45am ET BiomX Acquisition and Clinical Trial Successes Prompt Buy Rating by Analyst Michael Higgins by TipRanks Mar 07 6:27am ET BiomX Buy Rating Justified by Merger Synergy, Enhanced Financial Stability, and Promising Clinical Trials by TipRanks Mar 06 8:02am ET BiomX Merger and Strategic Equity Deals Reshape Future by TipRanks Mar 06 7:35am ET BiomX enters merger agreement with Adaptive Phage Therapeutics by TipRanks

No recent press releases are available for PHGE

PHGE Financials

1-year income & revenue

Key terms

PHGE Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

PHGE Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

A bubble tea store operated by Sichuan Baicha Baidao in Shanghai, China, on April 23, 2024.
Raul Ariano/Bloomberg/Getty Images
Is the tea bubble bursting? ChaPanda shares plunge in Hong Kong IPO
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Can markets make a comeback? That depends on tech earnings
People walk past the New York Stock Exchange Thursday, March. 21, 2024.
Yuki Iwamura/AP
Investors are fearful. They shouldn’t be
People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally